Article
Elevated plasma complement components in facioscapulohumeral dystrophy
16 Dec 2021
Abstract excerpt
Advances in understanding the pathophysiology of facioscapulohumeral dystrophy (FSHD) have led to several therapeutic approaches entering clinical trials and an increased need to develop biomarkers of disease activity and progression. Multiple prior studies have shown early elevation of RNAs encoding components of the complement pathways and relatively widespread activated complement complexes by immunodetection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
